FDA approves new kind of lymphoma treatment. Food and Drug Administration.
James
J S
JS
Dubs
G
G
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D016393:Lymphoma, B-Cell / Q000628:therapy*; D000069283:Rituximab; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab